Blog

Jonathan Spicer: An outstanding talk by Cecilia Pompili on early-stage lung cancer at ELIXR24

Collage photo of Jonathan Spicer and Cecilia Pompili

Jan 19, 2025, 05:47

Jonathan Spicer: An outstanding talk by Cecilia Pompili on early-stage lung cancer at ELIXR24

Jonathan Spicer, Medical Director of the Thoracic Oncology Program at McGill University, shared a post on X:

“An outstanding talk by Cecilia Pompili on the all important subject of patient-reported outcomes in early-stage lung cancer at ELIXR24.

So much to learn in this exciting field of early-stage lung cancer at ELIXR25.”

Amy Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared this post, adding:

“Proud to work with Drs. Cecilia Pompili, Jill Feldman, Narjust Florez, Jhanelle Gray, Cristiane Bergerot and more on a global Lung Cancer collaborative on perioperative PROs.”

Read further.

More posts featuring Jonathan Spicer and Amy Moore.

Jonathan Spicer, Assistant Professor and Medical Director of the Thoracic Oncology Program at McGill University, specializes in minimally invasive approaches to lung cancer and complex resections for advanced thoracic malignancies.

His research focuses on neutrophil-driven mechanisms of cancer metastasis, the interplay between inflammation and cancer, clinical trials for thoracic malignancies, airway surgery, and thoracic trauma.

Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science and Research at the Addario Lung Cancer Medical Institute (ALCMI).

She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.